Alkemy Capital Investments PLC (LSE: ALK), the investment company linked to the Tees Valley Lithium project, has announced a loan conversion resulting in the issue of 81,126 new ordinary shares. The conversion covers £100,000 of principal and £56,384.21 of accrued interest from an existing debt facility, converted at a price of £1.93 per share. The new shares are expected to be admitted to trading on the London Stock Exchange on 9 November 2026, expanding the company's total share capital to 11,324,446 ordinary shares.

Key Points

  • Alkemy Capital Investments PLC (LSE: ALK; JV2:FRA)
  • Debt facility provider has converted £100,000 principal and £56,384.21 interest into 81,126 new ordinary shares at £1.93 per share
  • Admission of new shares to the London Stock Exchange Main Market expected at 8:00 a.m. on 9 November 2026
  • Investors should watch the enlarged share capital figure of 11,324,446 ordinary shares, which now serves as the regulatory denominator for voting rights disclosures

Alkemy Capital Converts Debt Facility Tranche at £1.93 Per Share

Alkemy Capital Investments PLC has received a formal loan conversion notice from its debt facility provider, acting under terms disclosed in an earlier RNS dated 31 July 2025. The conversion encompasses £100,000 of outstanding principal alongside £56,384.21 of accrued interest, together converted at a fixed price of £1.93 per ordinary share. This results in the issue of 81,126 new ordinary shares of 2 pence each. Debt-to-equity conversions of this nature reduce a company's outstanding liabilities while simultaneously diluting existing shareholders, a dynamic investors in smaller listed companies will recognise.

New Ordinary Shares Admitted to LSE Main Market on 9 November 2026

The company has confirmed that an application will be made for the 81,126 new ordinary shares to be admitted to the Equity Shares (transition) category of the Official List and the Main Market of the London Stock Exchange. Admission is scheduled for 8:00 a.m. on 9 November 2026. The shares carry the same rights as existing ordinary shares in the company. The use of the Main Market, rather than AIM, reflects Alkemy's current listing structure, which also includes a Frankfurt listing under the ticker JV2. Zeus Capital is acting as the company's broker on this transaction.

Alkemy's Total Voting Rights Rise to 11,324,446 Ordinary Shares Following Admission

Following admission of the new shares, Alkemy's enlarged issued share capital will consist of 11,324,446 ordinary shares, each carrying voting rights. The company has notified the market of this figure in compliance with the FCA's Disclosure Guidance and Transparency Rules, as it represents the denominator shareholders must use when calculating whether they are required to disclose a notifiable interest or change in interest. Investors holding positions in ALK should review their holdings against this updated total to ensure compliance with applicable transparency obligations.

Tees Valley Lithium Connection Underlines Alkemy's Critical Minerals Focus

Alkemy Capital Investments is associated with the Tees Valley Lithium project, a domestic lithium production initiative with its own dedicated website referenced in the announcement. The company's focus on critical minerals positions it within a sector attracting significant policy and investor attention across the UK. The debt conversion announced here is a financial management action rather than an operational development, but it maintains the company's capital structure as it continues to develop its investment interests. The company did not disclose any operational update or revised project guidance alongside this announcement.